+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Muscular atrophy

Muscle atrophy is the wasting or loss of muscle tissue, leading to decreased muscle mass and strength. It can result from disuse, malnutrition, aging, nerve damage, or various underlying medical conditions such as muscular dystrophies, spinal muscular atrophy, or chronic diseases. Symptoms include muscle weakness, reduced mobility, and fatigue. Diagnosis involves physical examination, neurological assessment, and sometimes imaging or electromyography. Treatment focuses on addressing the underlying cause, physical therapy, and nutritional support to preserve muscle function.
Catalog No Product Description CAS No. Purity Structural Formula
BP1708
Feretoside
Feretoside can increase the expression of heat shock factor 1 (HSF1) by a factor of 1.153 at 3 uM.
27530-67-2 98% Feretoside
BP0262
Beta-Ecdysterone
20-hydroxyecdysone is an ecdysteroid that is ecdysone substituted by a hydroxy group at position 20. It has a role as an animal metabolite and a plant metabolite. It is an ecdysteroid, a phytoecdysteroid, a 3beta-sterol, a 20-hydroxy steroid, a 2beta-hydroxy steroid, a 14alpha-hydroxy steroid, a 22-hydroxy steroid and a 25-hydroxy steroid. It is functionally related to an ecdysone.
5289-74-7 98% Beta-Ecdysterone
BP1660
Carboxyatractyloside Potassium Salt
Carboxyatractyloside poisoning causes multiple organ dysfunction and can be fatal, the signs of a poor prognosis including coagulation abnormalities, hyponatraemia, marked hypoglycaemia, icterus and hepatic and renal failure, without antidote. Carboxyatractyloside can induce permeability transition, and that ageing induced mitochondrial DNA disruption and release of cytochrome c; it induces the inhibitory effect of tamoxifen on nonspecific membrane permeability.
77228-71-8 98% Carboxyatractyloside Potassium Salt
BP1780
25S-Inokosterone
25S-Inokosterone and 25R-inokosterone exhibit potent inhibition (80-95% at ) against TNF-expression levels in A23187 plus phorbol-myrisrate acetate-induced RBL-2H3 cells, they have excellent anti-atopy activity, thus they could be used to a large range of functional anti-atopy cosmetics.
19595-18-7 98% 25S-Inokosterone
BP5644 20853-88-7 Amarasterone A
BP5632 627511-34-6 24-Hydroxycyasterone
BP1673
Desoxyrhaponticin
Desoxyrhaponticin is an agent that is potentially effective in controlling postprandial hyperglycemia in diabetes. Desoxyrhaponticin could be considered as a promising fatty acid synthase(FAS) inhibitor, it could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.
30197-14-9 98% Desoxyrhaponticin
BP5620 851727-39-4 25-epi-28-Epicyasterone